RSS-Feed abonnieren
DOI: 10.1055/s-2005-921916
Original and Rapid Access to New Alkaloid Analogues of Neocryptolepine: Synthesis of Substituted 6-Methyl-6H-indolo[2,3-b]quinolines via TDAE Strategy
Publikationsverlauf
Publikationsdatum:
28. November 2005 (online)
![](https://www.thieme-connect.de/media/synlett/200520/lookinside/thumbnails/10.1055-s-2005-921916-1.jpg)
Abstract
We report herein an original and rapid synthesis of new substituted 6H-indolo[2,3-b]quinolines based on TDAE strategy from reaction between substituted o-nitrobenzyl chlorides and 1-methyl isatin followed by a one-pot reduction-cyclization-dehydration reaction.
Key words
TDAE - indolo[2,3-b]quinoline - alkaloids - reduction - 1-methyl isatin
-
1a
Cimanga K.De Bruyne T.Pieters L.Clayes M.Vlietinck A. Tetrahedron Lett. 1996, 37: 1703 -
1b
Sharaf MHM.Schiff PL.Tackie AN.Phoebe CH.Martin GE. J. Heterocycl. Chem. 1996, 33: 239 -
1c
Pousset J.-L.Martin M.-T.Jossang A.Bodo B. Phytochemistry 1995, 39: 735 -
2a
Kansal VK.Potier P. Tetrahedron 1986, 42: 2389 -
2b
Devarj R.Cushman M. Bioorg. Med. Chem. Lett. 1997, 7: 369 - 3
Molina A.Vaquero JJ.Garcia-Navio JL.Alvarez-Builla J.Pascual-Teresa B.Gago F.Rodrigo MM.Ballesteros M. J. Org. Chem. 1996, 61: 5587 - 4
Cimanga K.De Bruyne T.Pieters L.Vlietinck AJ.Turger CA. J. Nat. Prod. 1997, 60: 688 -
5a
Peczynska-Czoch W.Pognan F.Kaczmarek L.Boratynski J. J. Med. Chem. 1994, 37: 3503 -
5b
Kaczmarek L.Balicki R.Nantka-Namirski P.Peczynska-Czoch W.Mordarski M. Arch. Pharm. 1998, 321: 463 -
6a
Molina P.Alajarin M.Vidal A. J. Chem. Soc., Chem. Commun. 1990, 1277 -
6b
Molina P.Alajarin M.Vidal A.Sanchez-Andrada P. J. Org. Chem. 1992, 57: 929 -
6c
Chen Y.-L.Hung H.-M.Lu C.-M.Li K.-C.Tzeng C.-C. Bioorg. Med. Chem. 2004, 12: 6539 -
6d
Sundaram GSM.Venkatesh C.Syam Kumar UK.Ila H.Junjappa H. J. Org. Chem. 2004, 69: 5760 - 7
Molina P.Fresneda PM.Delgado S. Synthesis 1999, 326 - 8
Timari G.Soos T.Hajos G. Synlett 1997, 1067 - 9
Shi C.Zhang Q.Wang KK. J. Org. Chem. 1999, 64: 925 - 10
Kaczmarek L.Peczynska-Czoch W.Osiadacz J.Mordarski M.Sokalski WA.Boratynski J.Marcinkowska E.Glazman-Kusnierczyk H.Radzikowski C. Bioorg. Med. Chem. 1999, 7: 2457 -
11a
Engqvist R.Bergman J. Org. Prep. Proced. Int. 2004, 36: 386 -
11b
Alajarin M.Molina P.Vidal A. J. Nat. Prod. 1997, 60: 747 -
12a
Takechi N.Ait-Mohand S.Médebielle M.Dolbier WR. Tetrahedron Lett. 2002, 43: 4317 -
12b
Ait-Mohand S.Takechi N.Médebielle M.Dolbier WR. Org. Lett. 2001, 3: 4271 -
12c
Médebielle M.Keirouz R.Okada E.Ashida T. Synlett 2001, 821 -
12d
Dolbier WR.Médebielle M.Ait-Mohand S. Tetrahedron Lett. 2001, 42: 4811 - 13
Giuglio-Tonolo G.Terme T.Médebielle M.Vanelle P. Tetrahedron Lett. 2003, 44: 6433 - 14
Giuglio-Tonolo G.Terme T.Médebielle M.Vanelle P. Tetrahedron Lett. 2004, 45: 5121 - 15
Giuglio-Tonolo G.Terme T.Vanelle P. Synlett 2005, 251 -
16a
Terme T.Crozet MP.Maldonado J.Vanelle P. In Electron Transfer Reactions in Organic SynthesisVanelle P. Research Signpost; Trivandrum: 2002. p.1 -
16b
Terme T.Beziane A.Vanelle P. Lett. Org. Chem. 2005, 2: 367 -
17a
Amiri-Attou O.Terme T.Vanelle P. Molecules 2005, 10: 545 -
17b
Kantevari S.Narasimhaji CV.Mereyala HB. Tetrahedron 2005, 61: 5849 - 19
Artico M.Silvestri R.Pagnozzi E.Stefancich G.Massa S.Loi AG.Putzolu M.Corrias S.Spiga MG.La Colla P. Bioorg. Med. Chem. 1996, 837 - 21
Porter JC.Robinson R.Wyler M. J. Chem. Soc. 1941, 620
References
General Procedure for the Reaction of
o
-Nitrobenzyl Chloride (1a-e) and 1-Methyl Isatin (2), Using TDAE.
Into a two-necked flask equipped with a drying tube (silica gel) and a nitrogen inlet was added 6 mL of anhyd DMF solution of o-nitrobenzyl chloride (1a-e, 0.4 g, 1.8 mmol) and 1-methyl isatin (2, 0.8 g, 5.4 mmol, 3 equiv) at -20 °C. The solution was stirred and maintained at this temperature for 30 min and then the TDAE (0.42 g, 1.8 mmol) was added dropwise (via syringe). A red color immediately developed with the formation of a fine, white precipitate. The solution was vigorously stirred at -20 °C for 1 h and then warmed up to r.t. for 2 h. After this time TLC analysis (CH2Cl2) clearly showed that compounds (1a-e) was totally consumed. The orange-red turbid solution was filtered (to remove the octamethyl-oxamidinium dichloride) and hydrolyzed with 80 mL of H2O. The aqueous solution was extracted with CHCl3 (3 × 40 mL), the combined organic layers washed with H2O (3 × 40 mL) and dried over MgSO4. Evaporation of the solvent left an orange viscous liquid as crude product. Purification by silica gel chromatography (CH2Cl2) and recrystallization from EtOH gave the corresponding α-hydroxy derivatives.
New products: compound 3a: white solid; mp 176 °C. 1H NMR (200 MHz, DMSO-d
6): δ = 3.01 (s, 3 H), 3.25 (d, J
AB
= 13.4 Hz, 1 H), 3.65 (d, J
AB
= 13.4 Hz, 1 H), 6.20 (br s, 1 H), 6.70 (m, 1 H), 6.92 (m, 2 H), 7.26 (m, 2 H), 7.50 (s, 2 H), 7.78 (m, 1 H). 13C NMR (50 MHz, DMSO-d
6): δ = 25.9, 38.9, 75.6, 108.5, 122.3, 123.8, 124.2, 128.3, 129.4, 130.3, 132.1, 134.0, 142.8, 150.6, 176.8. The C-nitro was not observed in this experiment. Anal. Calcd for C16H14N2O4: C, 64.42; H, 4.73; N, 9.39. Found: C, 64.36; H, 4.80; N, 9.50.
Compound 3b: yellow solid; mp 201 °C. 1H NMR (200 MHz, DMSO-d
6): δ = 2.31 (s, 3 H), 3.01 (s, 3 H), 3.25 (d, J
AB
= 13.3 Hz, 1 H), 3.64 (d, J
AB
= 13.3 Hz, 1 H), 6.19 (br s, 1 H), 6.75 (m, 1 H), 6.92 (m, 2 H), 7.10 (s, 1 H), 7.26 (m, 2 H), 7.71 (m, 1 H). 13C NMR (50 MHz, DMSO-d
6): δ = 20.9, 25.9, 39.1, 75.7, 108.4, 122.2, 123.7, 124.4, 128.6, 129.3, 129.5, 130.4, 134.5, 142.6, 142.8, 148.2, 176.9. Anal. Calcd for C17H16N2O4: C, 65.38; H, 5.16; N, 8.97. Found: C, 65.60; H, 5.25; N, 9.08.
Compound 3c: yellow solid; mp 206 °C. 1H NMR (200 MHz, DMSO-d
6): δ = 3.02 (s, 3 H), 3.24 (d, J
AB
= 13.5 Hz, 1 H), 3.54 (d, J
AB
= 13.5 Hz, 1 H), 6.22 (br s, 1 H), 6.75 (m, 1 H), 6.94 (m, 2 H), 7.29 (m, 2 H), 7.67 (m, 1 H), 7.93 (m, 1 H). 13C NMR (50 MHz, DMSO-d
6): δ = 25.9, 38.4, 75.2, 108.6, 122.4, 123.7, 124.0, 128.5, 129.4, 130.3, 131.9, 132.2, 135.7, 142.7, 151.0, 176.6. Anal. Calcd for C16H13ClN2O4: C, 57.75; H, 3.94; N, 8.42. Found: C, 57.90; H, 4.00; N, 8.49.
Compound 3d: yellow solid; mp 233 °C. 1H NMR (200 MHz, DMSO-d
6): δ = 2.98 (s, 3 H), 3.36 (d, J
AB
= 13.3 Hz, 1 H), 3.63 (d, J
AB
= 13.3 Hz, 1 H), 3.70 (s, 3 H), 3.75 (s, 3 H), 6.19 (br s, 1 H), 6.76 (s, 1 H), 6.91 (m, 3 H), 7.25 (m, 1 H), 7.39 (s, 1 H). 13C NMR (50 MHz, DMSO-d
6): δ = 25.9, 38.9, 55.9, 56.0, 76.0, 107.9, 108.5, 115.6, 123.2, 123.8, 129.3, 130.5, 142.6, 142.9, 147.3, 151.3, 177.0. The C-nitro was not observed in this experiment. Anal. Calcd for C18H18N2O6: C, 60.33; H, 5.06; N, 7.82. Found: C, 60.37; H, 5.16; N, 7.80.
General Procedure for Reduction-Cyclization-Double Dehydration Step.
Iron powder (1.8 g, 33.6 mmol, 28 equiv) was added over a period of 0.5 h to a stirred solution of the appropriate starting material (3a-e,1.2 mmol) in glacial AcOH (68 mL) while heating at 110 °C, then the mixture was maintained at 110 °C for 48 h. After filtration on Celite® the solvent was evaporated under reduced pressure and the residue was neutralized with an aq solution of NaHCO3. After extraction with CHCl3 (3 × 30 mL), the combined organic layers washed with H2O (3 × 40 mL) and dried over MgSO4. Evaporation of the solvent left a viscous liquid as crude product. Purification by silica gel chromatography (CH2Cl2) and recrystallization from EtOH gave the corresponding 6-methyl-6H-indolo[2,3-b]quinolines (4a-e).
New products: compound 4a: orange solid; mp 57 °C. 1H NMR (200 MHz, CDCl3): δ = 3.82 (s, 3 H), 7.27 (m, 2 H), 7.50 (m, 2 H), 7.74 (m, 1 H), 7.90 (m, 1 H), 8.00 (m, 1 H), 8.17 (m, 1 H), 8.44 (s, 1 H). 13C NMR (50 MHz, CDCl3): δ = 27.4, 108.4, 117.8, 119.6, 120.1, 121.1, 122.6, 123.9, 126.9, 127.3, 127.8, 128.3, 128.6, 142.5, 146.6, 152.4. Anal. Calcd for C16H12N2: C, 82.73; H, 5.21; N, 12.06. Found: C, 82.56; H, 5.38; N, 12.00.
Compound 4b: orange solid; mp 106 °C. 1H NMR (200 MHz, CDCl3): δ = 2.58 (s, 3 H), 3.99 (s, 3 H), 7.36 (m, 2 H), 7.57 (m, 2 H), 7.76 (s, 1 H), 8.09 (m, 2 H), 8.63 (s, 1 H). 13C NMR (50 MHz, CDCl3): δ = 21.4, 27.7, 108.6, 118.1, 119.8, 120.5, 121.3, 124.1, 126.7, 127.2, 127.3, 127.9, 131.1, 132.4, 142.8, 145.3, 152.5. Anal. Calcd for C17H14N2: C, 82.90; H, 5.73; N, 11.37. Found: C, 83.01; H, 5.85; N, 11.56.
Compound 4c: white solid; mp 164 °C. 1H NMR (200 MHz, DMSO-d
6): δ = 3.90 (s, 3 H), 7.34 (m, 1 H), 7.48 (m, 1 H), 7.62 (m, 2 H), 8.02 (m, 1 H), 8.13 (m, 1 H), 8.27 (m, 1 H), 9.06 (s, 1 H). 13C NMR (50 MHz, DMSO-d
6): δ = 27.7, 109.6, 118.0, 119.6, 120.4, 121.9, 122.4, 123.4, 125.8, 127.9, 128.6, 130.6, 133.5, 142.6, 146.6, 152.6. Anal. Calcd for C16H11ClN2: C, 72.05; H, 4.16; N, 10.50. Found: C, 72.04; H, 4.24; N, 10.54.
Compound 4d: yellow solid; mp 216 °C. 1H NMR (200 MHz, CDCl3): δ = 3.97 (s, 3 H), 4.05 (s, 3 H), 4.09 (s, 3 H), 7.25 (s, 1 H), 7.27 (m, 1 H), 7.40 (m, 1 H), 7.48 (s, 1 H), 7.55 (m, 1 H), 8.10 (m, 1 H), 8.57 (s, 1 H). 13C NMR (50 MHz, CDCl3): δ = 27.7, 56.0, 56.1, 106.2, 106.7, 108.5, 116.1, 119.0, 119.6, 120.5, 120.8, 125.9, 127.2, 142.0, 143.7, 147.2, 152.0, 152.2. Anal. Calcd for C18H16N2O2: C, 73.95; H, 5.52; N, 9.58. Found: C, 73.98; H, 5.57; N, 9.62.
Compound 4e: yellow solid; mp 193 °C. 1H NMR (200 MHz, CDCl3): δ = 3.94 (s, 3 H), 6.09 (s, 2 H), 7.21 (s, 1 H), 7.27 (m, 1 H), 7.40 (m, 1 H), 7.44 (s, 1 H), 7.54 (m, 1 H), 8.07 (m, 1 H), 8.49 (s, 1 H). 13C NMR (50 MHz, CDCl3): δ = 27.6, 101.4, 103.5, 104.5, 108.6, 116.0, 119.6, 120.1, 120.3, 120.9, 126.3, 127.2, 142.0, 145.0, 145.3, 150.4, 151.8. Anal. Calcd for C17H12N2O2: C, 73.90; H, 4.38; N, 10.14. Found: C, 74.00; H, 4.40; N, 9.80.